EPHA4 and head and neck squamous cell carcinoma: Our study demonstrates how the compensatory mechanisms by upregulated EphA4 come into the concert when the preferred binding partner of ephrinB2, EphB4, is lost and by inhibiting EphA4 signaling, tumor growth inhibition can be effectively restored in HNSCC.